Efficacy and safety of the trans-obturator TVT-Abbrevo device in normal weight compared to overweight patients affected by stress urinary incontinence

ObjectiveTo investigate if TVT-Abbrevo has similar outcomes in normal weight and overweight patients.Study designRetrospective evaluation of 205 (105 normal weight women and 100 overweight women with BMI ≥ 25 kg/m2) undergone TVT-Abbrevo positioning with 12 month follow-up. Primary outcomes were objective cure rate (defined as no leakage during CST) and subjective cure rate (“very much improved”/“much improved” at PGI-I), secondary outcomes were intra-operative and post-operative complications.ResultsObjective cure rates in the normal and overweight groups were 96.2% and 94%, respectively (p = .47). Subjective cure rates in the normal and overweight groups were 90.5% and 88%, respectively (p = .57). ICIQ-SF, I-QoL and PGI-S scores significantly improved in both groups with no differences between the two groups. No serious intra- or post-operative complications were observed. No differences were observed in pain VAS scores and number of analgesic vials administered.ConclusionsTVT-Abbrevo seems to have similar efficacy and safety in normal weight and overweight women. More studies are needed to assess the efficacy of this device in frankly obese women and long-term outcomes.